BCL2L1 and neoplasm: In line with these results, other publications have already registered a rise in Bcl-XL expression after DCA incubation in several tumor types, such as lung adenocarcinoma, colorectal cancer [25] and oral squamous cell carcinoma [43], and, still, that did not stop the therapies from working.